EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments

Go back to EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments
(NASDAQ: EYPT) Delayed: 0.40 -0.03 (6.98%)
Previous Close $0.43    52 Week High $ 
Open $0.42    52 Week Low $ 
Day High $0.43    P/E N/A 
Day Low $0.40    EPS $ 
Volume 13,328,736